A small pilot study of such a protocol in BRCA1 gene mutation carriers found a substantial decrease in mammographic density (breast cancer risk surrogate) with no adverse effects on quality of life or bone mineral density [117]. This evidence concerns the gene BRCA1 and breast cancer.